上尿路尿路上皮癌根治性肾输尿管切除术后膀胱内复发的条件生存分析
在3家机构364例Ta-3N0M0局限性上尿路尿路上皮癌患者中,根治性肾输尿管切除术后5年膀胱内无复发生存率为41.5%,基于1至4年无事件生存的条件5年无复发生存率升至60.5%、73.4%、79.5%和96.7%;T2及以下分期和腹腔镜手术对膀胱内复发的影响随时间保持统计学效力。
要点
- 术后5年膀胱内无复发生存率为41.5%,条件生存率随无复发时间延长而升高。
- 基于1至4年生存的条件5年无复发生存率分别为60.5%、73.4%、79.5%和96.7%。
- T2及以下病理分期和腹腔镜根治性肾输尿管切除对膀胱内复发的影响随时间保持统计学效力。
核心结论
- 条件生存分析显示,局限性Ta-3N0M0上尿路尿路上皮癌患者根治性肾输尿管切除术后,膀胱内无复发生存概率随时间延长而升高。
- T2及以下T分期且接受腹腔镜根治性肾输尿管切除的患者,作者认为可推荐更长时间随访以发现后续膀胱内复发。
研究设计与样本
- 研究纳入3家机构中接受开放或腹腔镜根治性肾输尿管切除的364例Ta-3N0M0局限性上尿路尿路上皮癌患者。
- 采用Kaplan-Meier法计算条件膀胱内无复发生存率和癌症特异性生存率。
- 采用多因素Cox回归分析评估各参数对膀胱内复发的影响随时间的变化。
主要发现
- 根治性肾输尿管切除术后176例(48.4%)检测到膀胱内复发,93例(25.5%)死于局限性上尿路尿路上皮癌。
- 术后5年膀胱内无复发生存率为41.5%,癌症特异性生存率为72.9%。
- 基于1、2、3和4年生存的条件5年膀胱内无复发生存率分别从41.5%升至60.5%、73.4%、79.5%和96.7%。
- 基于1、2、3和4年生存的条件5年癌症特异性生存率分别从72.9%升至78.4%、85.4%、90.9%和95.5%。
- 已知预测因素对膀胱内复发条件生存的效应随时间减弱;相反,T2及以下病理分期和腹腔镜根治性肾输尿管切除的影响随时间保持统计学效力。
临床怎么用
- 作者认为,T2及以下T分期且接受腹腔镜根治性肾输尿管切除的患者可推荐更长时间随访以发现后续膀胱内复发。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Since conditional survival analysis provides better estimates of survival time at each followup, we assessed changes in conditional intravesical recurrence-free survival rates after radical nephroureterectomy. We also sought to determine how the impact of well-known risk factors evolves with time, particularly in patients with localized upper tract urothelial carcinoma. MATERIALS AND METHODS: We identified 364 patients with Ta-3N0M0 localized upper tract urothelial carcinoma who underwent open or laparoscopic radical nephroureterectomy at 1 of our 3 institutions. Conditional intravesical recurrence-free and cancer specific survival rates were calculated using the Kaplan-Meier method. The changing impact of parameters on intravesical recurrence with time was assessed by multivariate Cox regression analysis. RESULTS: Intravesical recurrence after radical nephroureterectomy was detected in 176 patients (48.4%) and 93 (25.5%) died of localized upper tract urothelial carcinoma. Five-year intravesical recurrence-free and cancer specific survival rates after surgery were 41.5% and 72.9%, respectively. Based on 1, 2, 3 and 4-year survivorship the 5-year conditional intravesical recurrence-free survival rate increased from 41.5% to 60.5%, 73.4%, 79.5% and 96.7%, respectively. The 5-year conditional cancer specific survival rate also improved from 72.9% to 78.4%, 85.4%, 90.9% and 95.5% at 1, 2, 3 and 4 years, respectively. The effects of well-known predictive factors on estimated conditional survival decreased with time for intravesical recurrence. In contrast, the impact of T2 or lower pathological stage and laparoscopic radical nephroureterectomy sustained statistical power with time. CONCLUSIONS: Conditional survival analysis revealed that the probability of intravesical recurrence-free survival increased with time in patients with localized Ta-3N0M0 upper tract urothelial carcinoma after radical nephroureterectomy. Patients with T2 or lower T stage who undergo laparoscopic radical nephroureterectomy may be recommended for longer followup to detect subsequent intravesical recurrence.
引用
- Shigeta K, Kikuchi E, Hagiwara M, et al. The Conditional Survival with Time of Intravesical Recurrence of Upper Tract Urothelial Carcinoma. J Urol. 2017. PMID: 28634017. doi:10.1016/j.juro.2017.06.073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。